Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medfirst Healthcare ServicesROCO:4175 -0.40%68 Return-on-Tangible-Equity is 13.89% as of Dec. 2025, which is 17% above its 10-year median of 11.85. GuruFocus rates ROCO:4175 with a GF Score™ of 68/100 and a GF Value™ of NT$74.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Medfirst Healthcare Services ranks better than 50.78% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medfirst Healthcare Services's annualized net income for the quarter that ended in Dec. 2025 was NT$208 Mil. Medfirst Healthcare Services's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$1,500 Mil. Therefore, Medfirst Healthcare Services's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 13.89%.
The historical rank and industry rank for Medfirst Healthcare Services's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:4175'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.4 Med: 11.85 Max: 15.86
Current: 10.6
During the past 13 years, Medfirst Healthcare Services's highest Return-on-Tangible-Equity was 15.86%. The lowest was 3.40%. And the median was 11.85%.
ROCO:4175's Return-on-Tangible-Equity is ranked better than 50.78% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs ROCO:4175: 10.60
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Medfirst Healthcare Services Return-on-Tangible-Equity Related Terms
Medfirst Healthcare Services Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Medfirst Healthcare Services's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medfirst Healthcare Services Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medfirst Healthcare Services's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Medfirst Healthcare Services's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.89% mean?
Medfirst Healthcare Services (ROCO:4175) has a Return-on-Tangible-Equity of 13.89% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medfirst Healthcare Services and its competitors. This is 17% above median its historical median of 11.85. Over the past decade, Medfirst Healthcare Services' Return-on-Tangible-Equity has ranged from 3.40 to 15.86. According to the industry distribution chart, Medfirst Healthcare Services ranks #284 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is Medfirst Healthcare Services' Return-on-Tangible-Equity too high?
Medfirst Healthcare Services' current Return-on-Tangible-Equity of 13.89% is 17% above median its 10-year median of 11.85. Over the past 10 years, this metric has ranged from a low of 3.40 to a high of 15.86. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Medfirst Healthcare Services' value of 13.89% is 37.1% above this industry median. Based on the distribution chart, Medfirst Healthcare Services ranks #284 out of 577 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medfirst Healthcare Services has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medfirst Healthcare Services' Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medfirst Healthcare Services ranks #284 out of 577 companies for Return-on-Tangible-Equity. This puts Medfirst Healthcare Services in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Medfirst Healthcare Services' value of 13.89% is 37.1% above this benchmark. Historically, Medfirst Healthcare Services' own Return-on-Tangible-Equity has ranged from 3.40 to 15.86 over the past decade. While the company's 10-year median is 11.85 vs. the industry median of 10.13, Medfirst Healthcare Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medfirst Healthcare Services's current Return-on-Tangible-Equity of 13.89% is 37.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medfirst Healthcare Services and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medfirst Healthcare Services's current Return-on-Tangible-Equity is 13.89%, which is 17% above median its own 10-year median of 11.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medfirst Healthcare Services stock overvalued right now?
Based on GuruFocus' analysis, Medfirst Healthcare Services (ROCO:4175) is currently considered Possible Value Trap. The stock's GF Value™ is NT$74.49, compared to a current price of NT$50.00 — trading 32.9% below its estimated fair value. The current Return-on-Tangible-Equity is 13.89%, which is 17% above median its 10-year median of 11.85 and 37.1% above the Healthcare Providers & Services industry median of 10.13. Medfirst Healthcare Services' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Medfirst Healthcare Services (ROCO:4175), the current Return-on-Tangible-Equity is 13.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medfirst Healthcare Services (ROCO:4175) Overvalued in 2026?
Based on GuruFocus' analysis, Medfirst Healthcare Services stock appears to be undervalued.
The current stock price of NT$50.00 is trading 32.9% below its estimated GF Value™ of NT$74.49.
GuruFocus considers Medfirst Healthcare Services to be Possible Value Trap.
Key valuation signals for ROCO:4175:
Return-on-Tangible-Equity: 13.89% (17% above median its 10-year median of 11.85)
GF Value™: NT$74.49 vs. price of NT$50.00 (32.9% below fair value)
Industry Position: 37.1% above the Healthcare Providers & Services median (#284 of 577)
No single metric tells the full story. See the ROCO:4175 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medfirst Healthcare Services Inc is mainly engaged in the sale of medical supplies and the management of shopping malls. The company's geographical segment includes Mainland China and Taiwan. It generates maximum revenue from Taiwan. The company derives a majority of its revenue from medical care products followed by health care.
68GF Score
Get the complete analysis for ROCO:4175
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4175 has been successfully added to your 
